Bizzari Jean-Pierre

Director at ADCT; Director at HALO

Sold, on record
$1.5M
Dollars the filings state
Form 4 sales
2
Latest Jun 17, 2024
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • ADCTADC Therapeutics SADirector
  • HALOHALOZYME THERAPEUTICS, INC.Director

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale HALOUnusual
    Aug 25, 2021 2021

    Sold 35,000 shares at $41.01 ($1.4M)

    Bizzari Jean-Pierre, Director

    Sold 40% of holdings ($3.6M position)52,544 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ADCTNo plan
    Jun 17, 2024 +1027 days

    Sold 6,995 shares at $2.89 ($20k)

    Bizzari Jean-Pierre, Director

    No 10b5-1 planSold 8.1% of holdings ($250k position)79,502 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice ADCTNotice
    Jun 17, 2024 same day

    Filed to sell 6,995 shares ($20k)

    Bizzari Jean-Pierre, Director

    No 10b5-1 planFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Bizzari Jean-Pierre
Source
Jun 17, 2024Jun 18, 2024ADCTDirectorForm 144 notice6,995$20kNoticeSEC
Jun 17, 2024Jun 18, 2024ADCTDirectorForm 4 sale6,995$20k8.1%No planSEC
Aug 25, 2021Aug 25, 2021HALODirectorForm 4 sale35,000$1.4M40.0%UnusualSEC